Related references
Note: Only part of the references are listed.In Vivo Assessment of Vesicular Monoamine Transporter Type 2 in Dementia With Lewy Bodies and Alzheimer Disease
Victor L. Villemagne et al.
ARCHIVES OF NEUROLOGY (2011)
Serotonin 5-HT6 receptor blockade reverses the age-related deficits of recognition memory and working memory in mice
Virginie Da Silva Costa-Aze et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity
Andreas Gravius et al.
BEHAVIOURAL PHARMACOLOGY (2011)
Synthesis and in vivo evaluation of [O-methyl-11C] N-[3,5-dichloro-2-(methoxy)phenyl]-4-(methoxy)-3-(1-piperazinyl)benzenesulfonamide as an imaging probe for 5-HT6 receptors
Fei Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
The pyramidal neurons in the medial prefrontal cortex show decreased response to 5-hydroxytryptamine-3 receptor stimulation in a rodent model of Parkinson's disease
Qiao Jun Zhang et al.
BRAIN RESEARCH (2011)
Brainstem changes in 5-HT1A receptor availability during migraine attack
G. Demarquay et al.
CEPHALALGIA (2011)
Therapeutic Role of 5-HT1A Receptors in The Treatment of Schizophrenia and Parkinson's Disease
Yukihiro Ohno
CNS NEUROSCIENCE & THERAPEUTICS (2011)
5-HT6 receptor and cognition
Xabier Codony et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Synthesis and biological evaluation of potential 5-HT7 receptor PET radiotracers
Julien Andries et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Measuring serotonin synthesis: from conventional methods to PET tracers and their (pre)clinical implications
Anniek K. D. Visser et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT2A agonist PET tracers
Anders Ettrup et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists
Matthias F. Seidel et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder
Swen Hesse et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
In vivo serotonin-sensitive binding of [C-11]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer
Matthew S. Milak et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Quantitative analysis of [C-11]AZ10419369 binding to 5-HT1B receptors in human brain
Katarina Varnas et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Serotonin transporter binding in the hypothalamus correlates negatively with tonic heat pain ratings in healthy subjects: A [11C]DASB PET study
Ron Kupers et al.
NEUROIMAGE (2011)
Vesicular Monoamine Transporters: Structure-Function, Pharmacology, and Medicinal Chemistry
Kandatege Wimalasena
MEDICINAL RESEARCH REVIEWS (2011)
Influence of social isolation in the rat on serotonergic function and memory - Relevance to models of schizophrenia and the role of 5-HT6 receptors
Charles A. Marsden et al.
NEUROPHARMACOLOGY (2011)
Pharmacological Blockade of 5-HT7 Receptors as a Putative Fast Acting Antidepressant Strategy
Ouissame Mnie-Filali et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Development of a PET radioligand for the central 5-HT1B receptor: radiosynthesis and characterization in cynomolgus monkeys of eight radiolabeled compounds
Jan D. Andersson et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Ontogeny and regulation of the serotonin transporter: Providing insights into human disorders
Lynette C. Daws et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Therapeutics of 5-HT3 receptor antagonists: Current uses and future directions
Tina K. Machu
PHARMACOLOGY & THERAPEUTICS (2011)
Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders
Marcello Leopoldo et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects
S. M. Burke et al.
PSYCHOLOGICAL MEDICINE (2011)
Relationship of monoamine oxidase A binding to adaptive and maladaptive personality traits
A. Soliman et al.
PSYCHOLOGICAL MEDICINE (2011)
Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder
James W. Murrough et al.
PSYCHOPHARMACOLOGY (2011)
Cognitive function is related to fronto-striatal serotonin transporter levels - a brain PET study in young healthy subjects
Karine Madsen et al.
PSYCHOPHARMACOLOGY (2011)
Central serotonin transporter levels are associated with stress hormone response and anxiety
Matthias Reimold et al.
PSYCHOPHARMACOLOGY (2011)
Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369
Katarina Varnas et al.
PSYCHOPHARMACOLOGY (2011)
In Vivo Kinetics of [F-18]MEFWAY: A Comparison With [C-11]WAY100635 and [F-18]MPPF in the Nonhuman Primate
D. W. Wooten et al.
SYNAPSE (2011)
Serotonin-3 receptors in the posterior ventral tegmental area regulate ethanol self-administration of alcohol-preferring (P) rats
Zachary A. Rodd et al.
ALCOHOL (2010)
GPCR Interacting Proteins (GIPs) in the Nervous System: Roles in Physiology and Pathologies
Joel Bockaert et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Higher Serotonin 1A Binding in a Second Major Depression Cohort: Modeling and Reference Region Considerations
Ramin V. Parsey et al.
BIOLOGICAL PSYCHIATRY (2010)
Serotonin 1B Receptor Imaging in Alcohol Dependence
Jian Hu et al.
BIOLOGICAL PSYCHIATRY (2010)
Design, synthesis and structure-activity relationship of novel quinoxalin-2-carboxamides as 5-HT3 receptor antagonists for the management of depression
Radhakrishnan Mahesh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Vesicular Monoamine Transporters (VMATs) in Adrenal Chromaffin Cells: Stress-Triggered Induction of VMAT2 and Expression in Epinephrine Synthesizing Cells
Andrej Tillinger et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2010)
Acute treatment of migraine with the selective 5-HTIF receptor agonist lasmiditan - A randomised proof-of-concept trial
Michel D. Ferrari et al.
CEPHALALGIA (2010)
Medicinal Chemistry of 5-HT5A Receptor Ligands: A Receptor Subtype with Unique Therapeutical Potential
Balazs Volk et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Development of Effective PET and SPECT Imaging Agents for the Serotonin Transporter: Has a Twenty-Year Journey Reached its Destination?
Yiyun Huang et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Central serotonin 1A receptor binding in temporal lobe epilepsy: A [carbonyl-11C]WAY-100635 PET study
Eva Assem-Hilger et al.
EPILEPSY & BEHAVIOR (2010)
Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population
Taro Kishi et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions
Rupert Lanzenberger et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Kinetic modeling of the serotonin 5-HT1B receptor radioligand [C-11]P943 in humans
Jean-Dominique Gallezot et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Measuring endogenous 5-HT release by emission tomography: promises and pitfalls
Louise M. Paterson et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Synthesis, Structure-Affinity Relationships, and Radiolabeling of Selective High-Affinity 5-HT4 Receptor Ligands as Prospective Imaging Probes for Positron Emission Tomography
Rong Xu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
In Vivo Measurement of Vesicular Monoamine Transporter Type 2 Density in Parkinson Disease with 18F-AV-133
Nobuyuki Okamura et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
In Vivo Quantification of Human Serotonin 1A Receptor Using 11C-CUMI-101, an Agonist PET Radiotracer
Matthew S. Milak et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Antiangiogenic Effect of a Selective 5-HT4 Receptor Agonist
Takeshi Nishikawa et al.
JOURNAL OF SURGICAL RESEARCH (2010)
Cerebral serotonin transporter binding is inversely related to body mass index
D. Erritzoe et al.
NEUROIMAGE (2010)
Brain imaging of serotonin 4 receptors in humans with [11C]SB207145-PET
Lisbeth Marner et al.
NEUROIMAGE (2010)
5-HT1F Receptor Agonists: A New Treatment Option for Migraine Attacks?
Lars Neeb et al.
NEUROTHERAPEUTICS (2010)
Radiosynthesis and in vivo evaluation of [11C]-labelled pyrrole-2-carboxamide derivates as novel radioligands for PET imaging of monoamine oxidase A
Sylvie De Bruyne et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
18F-Labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging
Fabian Debus et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
An improved radiosynthesis of [18F]AV-133: a PET imaging agent for vesicular monoamine transporter 2
Lin Zhu et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease
Julie L. Wang et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
High-resolution imaging of brain 5-HT1B receptors in the rhesus monkey using [11C]P943
Nabeel Nabulsi et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data
Anna Wesolowska
PHARMACOLOGICAL REPORTS (2010)
Association Study between 5-HT1A Receptor Gene C(-1019)G Polymorphism and Panic Disorder in a Korean Population
Won-Seok Choi et al.
PSYCHIATRY INVESTIGATION (2010)
Influence of a Low Dose of Amphetamine on Vesicular Monoamine Transporter Binding: A PET (+)[11C]DTBZ Study in Humans
Isabelle Boileau et al.
SYNAPSE (2010)
The Serotonin-1A Receptor in Anxiety Disorders
Elena Akimova et al.
BIOLOGICAL PSYCHIATRY (2009)
Brain serotonin transporter binding in former users of MDMA ('ecstasy')
Sudhakar Selvaraj et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
The 5-HT1B Receptor: A Novel Target for the Pathophysiology of Depression
B. M. Ruf et al.
CURRENT DRUG TARGETS (2009)
Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: Interaction studies with citalopram
Robert L. Gannon et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Aggression is Related to Frontal Serotonin-1A Receptor Distribution as Revealed by PET in Healthy Subjects
A. Veronica Witte et al.
HUMAN BRAIN MAPPING (2009)
Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram
Siegfried Kasper et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2009)
Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population
Adelina Yosifova et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
Evaluation of the novel 5-HT4 receptor PET ligand [C-11]SB207145 in the Gottingen minipig
Birgitte R. Kornum et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Cerebral Monoamine Oxidase A Inhibition in Tobacco Smokers Confirmed With PET and [11C]Befloxatone
Claire Leroy et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Design, Synthesis, and Biological Evaluation of New 5-HT4 Receptor Agonists: Application as Amyloid Cascade Modulators and Potential Therapeutic Utility in Alzheimer's Disease
Olivier Russo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Nonmotor Symptoms of Parkinson's Disease Revealed in an Animal Model with Reduced Monoamine Storage Capacity
Tonya N. Taylor et al.
JOURNAL OF NEUROSCIENCE (2009)
Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders
C. Spindelegger et al.
MOLECULAR PSYCHIATRY (2009)
The personality trait openness is related to cerebral 5-HTT levels
Jan Kalbitzer et al.
NEUROIMAGE (2009)
5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor
Jonathan Shelton et al.
NEUROPHARMACOLOGY (2009)
Elevated Serotonin 1A Binding in Remitted Major Depressive Disorder: Evidence for a Trait Biological Abnormality
Jeffrey M. Miller et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Regulation and Physiological Functions of G12/13-Mediated Signaling Pathways
Nobuchika Suzuki et al.
NEUROSIGNALS (2009)
Regional distribution and behavioral correlates of 5-HT2A receptors in Alzheimer's disease with [18F]deuteroaltanserin and PET
Lekshmi Santhosh et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2009)
Positron Emission Tomography Imaging of Amphetamine-Induced Dopamine Release in the Human Cortex: A Comparative Evaluation of the High Affinity Dopamine D2/3 Radiotracers [11C]FLB 457 and [11C]Fallypride
Rajesh Narendran et al.
SYNAPSE (2009)
Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist:: a pilot study
J. M. Jarcho et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Molecular biology of 5-HT receptors
Jason Hannon et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
The effects of the 5-HT6 receptor agonist EMD and the 5-HT7 receptor agonist AS19 on memory formation
A. Meneses et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat
Jaime M. Monti et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine:: A positron-emission tomography study in healthy volunteers
Igor Sibon et al.
BIOLOGICAL PSYCHIATRY (2008)
PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy
Adrien Didelot et al.
BRAIN (2008)
Serotonin 5-HT1A receptor binding in people with panic disorder:: positron emission tomography study
Jon R. Nash et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Synthesis of new carbon-11 labeled benzoxazole derivatives for PET imaging of 5-HT3 receptor
Mingzhang Gao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
Modeling considerations for 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET
Matthew S. Milak et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Multimodal imaging of human early visual cortex by combining functional and molecular measurements with fMRI and PET
Florian Gerstl et al.
NEUROIMAGE (2008)
Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients
David Erritzoe et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Selective 5-HT6 receptor ligands:: Progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders
D. J. Heal et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Serotonin research: contributions to understanding psychoses
Mark A. Geyer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635
Jussi Hirvonen et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Stimulation of 5-HT1A, 5-HT1B, 5-HT2A/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition:: Short- and long-term memory
Alfredo Meneses
BEHAVIOURAL BRAIN RESEARCH (2007)
Serotonin-1A receptor imaging in recurrent depression: replication and literature review
Wayne C. Drevets et al.
NUCLEAR MEDICINE AND BIOLOGY (2007)
Vmat2 heterozygous mutant mice display a depressive-like phenotype
Masato Fukui et al.
JOURNAL OF NEUROSCIENCE (2007)
Paradoxical constitutive behavioral sensitization to amphetamine in mice lacking 5-HT2A receptors
Lucas Salomon et al.
PSYCHOPHARMACOLOGY (2007)
Reduced serotonin-1A receptor binding in social anxiety disorder
Rupert R. Lanzenberger et al.
BIOLOGICAL PSYCHIATRY (2007)
Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome
Steven Haugbol et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder
Peter B. Hedlund et al.
NEUROSCIENCE LETTERS (2007)
PET [11C]DASB imaging of serotonin transporters in patients with alcoholism
Amira K. Brown et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2007)
5-HT1A receptors and memory
Alfredo Meneses et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2007)
Constitutive deletion of the serotonin-7 (5-HT7) receptor decreases electrical and chemical seizure thresholds
Jeffrey M. Witkin et al.
EPILEPSY RESEARCH (2007)
Elevated monoamine oxidase A levels in the brain - An explanation for the monoamine imbalance of major depression
Jeffrey H. Meyer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Cytokines and serotonin transporter in patients with major depression
Chiung-Wen Tsao et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig:: A dual tracer PET study with [11C]Harmine and [11C]Raclopride
SB Jensen et al.
SYNAPSE (2006)
Effects of early life stress on [11C] DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys
M Ichise et al.
JOURNAL OF NEUROSCIENCE (2006)
Medicinal chemistry strategies to 5-HT6 receptor ligands as potential cognitive enhancers and antiobesity agents
J Holenz et al.
DRUG DISCOVERY TODAY (2006)
Increased serotonin receptor availability in human sleep:: Evidence from an [18F]MPPF PET study in narcolepsy
C Derry et al.
NEUROIMAGE (2006)
Positron emission tomography quantification of [11C]-harmine binding to monoamine oxidase-A in the human brain
N Ginovart et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)
Regional distribution and relative abundance of serotonin2c receptors in human brain:: Effect of suicide
GN Pandey et al.
NEUROCHEMICAL RESEARCH (2006)
5-ht(5A) receptors as a therapeutic target
David R. Thomas
PHARMACOLOGY & THERAPEUTICS (2006)
Neuroprotective effect of a chuk-me-sun-dan on neurons from ischemic damage and neuronal cell toxicity
TW Chung et al.
NEUROCHEMICAL RESEARCH (2006)
SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino) ethyl]-N-[(4'-{[2-phenylethyl)amino]methyl}-4-biphenylyl) methyl]propanamide dihydrochloride), a novel 5-ht(54) receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-Ht(5A) receptor in guinea pig brain
David R. Thomas et al.
NEUROPHARMACOLOGY (2006)
Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression
Anna Wesolowska et al.
NEUROPHARMACOLOGY (2006)
Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors
D Popa et al.
JOURNAL OF NEUROSCIENCE (2005)
5-HT1B receptors and aggression:: A review
B Olivier et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Increasing blood oxygen increases an index of 5-HT synthesis in human brain as measured using α-[11C]methyl-L-tryptophan and positron emission tomography
M Nishikawa et al.
NEUROCHEMISTRY INTERNATIONAL (2005)
Translational neuroimaging: Positron emission tomography studies of monoamine oxidase
JS Fowler et al.
MOLECULAR IMAGING AND BIOLOGY (2005)
Stability of α-[11C] methyl-L-tryptophan brain trapping in healthy male volunteers
P Rosa-Neto et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [Carbonyl11C]WAY-100635
UF Bailer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB
UD McCann et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei
KH Adams et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Decreased platelet vesicular monoamine transporter density in habitual smokers
K Schwartz et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)
Reduced serotonin type 1A receptor binding in panic disorder
A Neumeister et al.
JOURNAL OF NEUROSCIENCE (2004)
Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice
V Compan et al.
JOURNAL OF NEUROSCIENCE (2004)
Autoradiographic distribution of 5-HT7 receptors in the human brain using [H-3]mesulergine: comparison to other mammalian species
FJ Martin-Cora et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Measurement of brain regional α-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression
P Rosa-Neto et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Association of 5-HT1B receptor gene and antisocial behavior in alcoholism
M Soyka et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Serotonin transporters in obsessive-compulsive disorder:: A positron emission tomography study with [11C]McN 5652
HB Simpson et al.
BIOLOGICAL PSYCHIATRY (2003)
The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor
MR Guscott et al.
NEUROPHARMACOLOGY (2003)
Mapping the cerebral monoamine oxidase type A:: Positron emission tomography characterization of the reversible selective inhibitor [11C]befloxatone
M Bottlaender et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
5-HT2A receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls:: a PET study
C Messa et al.
PSYCHOPHARMACOLOGY (2003)
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
TF Massoud et al.
GENES & DEVELOPMENT (2003)
Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism
YY Huang et al.
NEUROPSYCHOPHARMACOLOGY (2003)
The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder
JF Quist et al.
MOLECULAR PSYCHIATRY (2003)
Candidate genes for anorexia nervosa in the 1 p33-36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa
AW Bergen et al.
MOLECULAR PSYCHIATRY (2003)
Reduced 5-HT2A receptor binding after recovery from anorexia nervosa
GK Frank et al.
BIOLOGICAL PSYCHIATRY (2002)
Synthesis and preliminary PET study of the 5-HT7 receptor antagonist [11C]DR4446
MR Zhang et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2002)
Serotonin1A receptor activation and hypothermia in humans:: Lack of evidence for a presynaptic mediation
P Blier et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Monoamine oxidase: radiotracer development and human studies
JS Fowler et al.
METHODS (2002)
Effects of the 5-HT6 receptor antagonist, SB-271046, in animal models for schizophrenia
B Pouzet et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Selective seratonin 1F (5-HT1F) receptor agonist LY334370 for acute migraine:: a randomised controlled trial
DJ Goldstein et al.
LANCET (2001)
Novel and previously reported single-nucleotide polymorphisms in the human 5-HT1Breceptor gene:: No association with cocaine or alcohol abuse or dependence
T Cigler et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2001)
Effects of rapid tryptophan depletion on brain 5-HT2 receptors:: a PET study
LN Yatham et al.
BRITISH JOURNAL OF PSYCHIATRY (2001)
Brain regional α-[11C]Methyl-L-Tryptophan trapping in impulsive subjects with borderline personality disorder
M Leyton et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
5-HT7 receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons
H Errico et al.
NEUROSCIENCE (2001)
Imaging the serotonin transporter with positron emission tomography:: initial human studies with [11C]DAPP and [11C]DASB
S Houle et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
Psychological and physiological effects of MDMA (ecstasy) after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans
ME Liechti et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Share Paper
